Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 8—August 2008

Detection and Molecular Characterization of a Canine Norovirus

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Vito Martella*Comments to Author , Eleonora Lorusso*, Niccola Decaro*, Gabriella Elia*, Arianna Radogna*, Maria D’Abramo*, Costantina Desario*, Alessandra Cavalli*, Marialaura Corrente*, Michelle Camero*, Cinzia A. Germinario*, Krisztian Bányai†, Barbara Di Martino‡, Fulvio Marsilio‡, Leland E. Carmichael§, and Canio Buonavoglia*
Author affiliations: *University of Bari, Bari, Italy; †Hungarian Academy of Sciences, Budapest, Hungary; ‡Cornell University, Ithaca, New York, USA; §University of Teramo, Teramo, Italy;

Cite This Article


We identified a novel calicivirus in a pup with enteritis. The isolate was related genetically (90.1% aa identity in the capsid protein) to a lion norovirus strain.

Caliciviridae are small, nonenveloped viruses, ≈35 nm in diameter with single-stranded, positive-polarity RNA genomes of 7.4–8.3 kb (1). Unlike calicivirus infections in cats, caliciviruses are not regarded as important pathogens in dogs and are not usually included in diagnostic algorithms for canine infectious diseases. Calicivirus-like particles have been occasionally identified by electron microscopy in specimens from dogs with diarrhea and, in some instances, glossitis, balanitis, or vesicular vaginitis. Most of these isolates were feline caliciviruses (Vesivirus genus) and were likely acquired from cats (2,3).

Thus far, only 2 documented reports have identified authentic canine caliciviruses in dogs. A calicivirus was isolated from the feces of a 4-year-old dog with bloody diarrhea and central nervous system disturbance in 1985 (Tennessee, USA). The virus replicated in experimentally infected dogs and elicited seroconversion, although disease was not reproduced. The virus was antigenically unrelated to feline calicivirus, and antibodies against the virus were identified in 76% of the canine serum specimens collected (4). However, the virus was not characterized molecularly, and its taxonomic status remains uncertain.

In 1990, another calicivirus was identified in Japan in a 2-month-old pup with intermittent fluid diarrhea (5). The virus, strain 48, was antigenically and genetically unrelated to feline calcivirus, was tentatively proposed as a “true” canine calicivirus (CaCV), and was included in the Vesivirus genus (6). Antibodies to CaCV 48 have been detected in 57% of dogs in Japan (7) and in 36.5% of dogs in South Korea (8). In this report, we describe the detection of a novel enteric CaCV.

The Study

A gastroenteric disease with diarrhea and vomiting developed in a 60-day-old mixed-breed pup. Because of severe dehydration, the pup was hospitalized 3 days after onset of the gastroenteric symptoms. After 4 days of illness, the dog recovered completely. At the time of the dog’s hospitalization, feces were collected and screened for common canine viral pathogens; test results were positive for canine parvovirus type-2a (CPV-2a). By using a broadly reactive primer pair, p289–p290, targeted to highly conserved motives “DYSKWDST” and “YGDD” of the RdRp region of the polymerase complex, we found, unexpectedly, that stool also tested positive for calicivirus (9). After the detection of calicivirus RNA in the dog’s feces, the animal was kept under observation, and fecal samples were collected daily from 11 to 30 days posthospitalization (dph) to monitor virus shedding. CPV-2a DNA was detected until dph 10, whereas calicivirus RNA was detected until dph 22.

To determine the sequence and genomic organization of the novel calicivirus, a 3.4-kb region at the 3′ end of the genome was amplified by reverse transcription–PCR (RT-PCR) as described by Wang et al. (10), cloned into a vector, and sequenced. The sequence (3381 nt) from the 3′ end of open reading frame 1 (ORF1) to the poly-A tail of the CaCV (strain 170/07) was made available in GenBank (accession no. EU224456).

Figure 1

Thumbnail of Figure 1 - Genome organization of the canine norovirus GIV.2/Bari/170/07/ITA. The genome (from the 3′ end of open reading frame 1 [ORF1] to the poly-A tail) of the canine strain and of the human GGIV.1 norovirus, Fort Lauderdale/560/98/US (AF414426) was plotted against the genome of the strain lion/GGIV.2/Pistoia/387/06/ITA (EF450827). Sequences were analyzed with Simplot (11) by using a window size of 200 nt and step size of 20 nt with gap strip off and Hamming correction

Figure 1. Genome organization of the canine norovirus GIV.2/Bari/170/07/ITA. The genome (from the 3′ end of open reading frame 1 [ORF1] to the poly-A tail) of the canine strain and of the human...

The 3.4-kb fragment of the calicivirus genome (the 3′ end of ORF1, the full-length ORF2, ORF3, and the noncoding region through the poly-A tail), is represented in Figure 1. The 3′ partial sequence of ORF1 spanned 824 nt and 273 aa at the COOH– terminus of the polymerase complex. Using BLAST ( and FASTA ( analysis, we found the highest identity (84.6% nt and 96.7% aa) in a lion norovirus strain, Pistoia/387/06/ITA (12). A 14-nt overlap was present in the ORF1–ORF2 junction region, as with most described human and animal noroviruses. The ORF2 was 1737-nt long and predicted to encode for a capsid protein with a size of 578 aa. The highest sequence match was found to the lion GGIV.2 norovirus strain Pistoia/387/06/ITA (90.1% aa and 81.13% nt), while the identity was 69.4%–68.2% aa (75.5%–74.0% nt) to GIV.1 NoVs and <53.3% aa (<67.4% nt) to non–GGIV NoVs. There was a single nt overlap between ORF2 and ORF3; also, there was a 55-nt long nontranslated region between ORF3 and the poly-A tail. ORF3 was 783 nt in length and encoded for a 260-aa polypeptide.

Figure 2

Thumbnail of Figure 2&nbsp;-&nbsp;Phylogenetic tree constructed on the full-length amino acid sequence of the capsid protein. The tree was constructed by using a selection of norovirus (NoV) strains representative of the genogroups I to V. Phylogenetic analysis (neighbor-joining) with bootstrap analysis (1,000 replicates) and Kimura 2-parameter correction was conducted by using the MEGA software package version 3.0 (14). Strains designation follows the outlines of Wang et al. (10) and Zheng et a

Figure 2. Phylogenetic tree constructed on the full-length amino acid sequence of the capsid protein. The tree was constructed by using a selection of norovirus (NoV) strains representative of the genogroups I to...

A nucleotide identity plot of the canine norovirus genome 170/07 (from the 3′ end of ORF1 to the poly-A tail) was compared with the lion GIV.2 NoV Pistoia/387/06/ITA and the human GGIV.1 norovirus, Fort Lauderdale/560/98/US (AF414426) (Figure 1). The 3′ genome of the canine norovirus 170/07 displayed high nucleotide conservation with the lion norovirus strain. A phylogenetic tree was constructed by using the capsid protein of selected human and animal noroviruses of the various norovirus genogroups (GGI to V) (10,13). In the tree (Figure 2), the canine calicivirus (strain 170/07) was grouped with the lion GGIV.2 norovirus strain Pistoia/387/06/ITA and with the GGIV.1 human NoVs Alphatron/98–2/98/NLD, Saint Cloud/624/98/US and FortLauderdale/560/98/US.


Noroviruses are regarded as the major cause of epidemic, nonbacterial gastroenteritis worldwide in humans of all age groups. The viruses are highly contagious and are transmitted by direct contact or by contaminated water and food (15). Because of the possibility of genetic recombination, a consistent and reliable classification of norovirus relies on the analysis of the complete capsid gene (13). Strains within the same genotype (or cluster) share >85% aa identity, while strains of different genotypes within the same genogroup share 55%–85% aa identity (13). Human noroviruses are classified into genogroups I, II, and IV. In addition, noroviruses detected in pigs, cows, and mice are classified in genogroups II, III, and V (13) (Table). Recently, a norovirus strain (Pistoia/387/06/ITA) was identified in a captive lion cub with severe hemorrhagic enteritis. By sequence analysis, the virus was found to resemble human GIV norovirus and was classified as a distinct genotype, GIV.2, whereas the human GIV noroviruses are genotype 1 (12). The canine norovirus strain 170/07 appeared to be most related genetically to the lion GGIV.2 norovirus (90.1% aa identity in the capsid protein); therefore, the virus may be considered as a variant of the genotype GGIV.2. Taken together, these findings suggest that noroviruses genetically similar to human GIV noroviruses are harbored in domestic and wild carnivores.

The pathogenic potential of this novel calicivirus in carnivores remains to be elucidated. In the pup, the norovirus strain was detected in conjunction with a CPV-2a strain that was likely responsible for the severity of the observed clinical signs, since CPV-2 is a major enteric pathogen of dogs. Accordingly, it is difficult to speculate on the pathogenic potential of the novel calicivirus for dogs and experimental infections in gnotobiotic dogs are required. Nevertheless, the norovirus 170/07 was detected in the subject pup for at least 22 days, which indicates active viral replication; the possibility of passive viral transit (mechanical passage) in the intestinal tract seems unlikely.

In conclusion, our study presents evidence for the existence of a novel calicivirus with enteric tropism that is related genetically to GGIV noroviruses and able to infect dogs. Future large-scale virologic and serologic investigations are needed to assess the ecology of this novel virus in wild and domestic carnivores. Also, because of the extensive social interactions between humans and pets, investigating the zoonotic potential of such animal noroviruses in humans is worthwhile.

Dr Martella is associate professor at the Faculty of Veterinary Medicine of Bari, Italy. His research involves diagnosis, epidemiology, and characterization of enteric viruses, including rotaviruses and caliciviruses, in animals and humans.



We thank Marion Koopmans for her comments and suggestions and Donato Narcisi for his technical support.

The work was partially financed by grants from the University of Bari, Italy, and from the Italian Ministry of University and Research.



  1. Green KY, Chanock RM, Kapikian AZ. Human caliciviruses. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed., vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 841–74.
  2. Crandell RA. Isolation and characterization of caliciviruses from dogs with vesicular genital diseases.Arch Virol. 1988;98:6571. DOIPubMedGoogle Scholar
  3. Martella V, Pratelli A, Gentile M, Buonavoglia D, Decaro N, Fiorente P, Analysis of the capsid protein gene of a feline-like calicivirus isolated from a dog.Vet Microbiol. 2002;85:31522. DOIPubMedGoogle Scholar
  4. Schaffer FL, Soergel ME, Black JW, Skilling DE, Smith AW, Cubitt WD. Characterization of a new calicivirus isolated from feces of a dog.Arch Virol. 1985;84:18195. DOIPubMedGoogle Scholar
  5. Mochizuki M, Kawanishi A, Sakamoto H, Tashiro S, Fujimoto R, Ohwaki M. A calicivirus isolated from a dog with fatal diarrhoea.Vet Rec. 1993;132:2212.PubMedGoogle Scholar
  6. Matsuura Y, Tohya Y, Nakamura K, Shimojima M, Roerink F, Mochizuki M, Complete nucleotide sequence, genome organization and phylogenetic analysis of the canine calicivirus.Virus Genes. 2002;25:6773. DOIPubMedGoogle Scholar
  7. Mochizuki M, Hashimoto M, Roerink F, Tohya T, Matsuura Y, Sasaki N. Molecular and seroepidemiological evidence of canine calicivirus infections in Japan.J Clin Microbiol. 2002;40:262931. DOIPubMedGoogle Scholar
  8. Jang HK, Tohya Y, Han KY, Kim TJ, Son CS, Mochizuki M. Seroprevalence of canine calicivirus and canine minute virus in the Republic of Korea.Vet Rec. 2003;153:1502.PubMedGoogle Scholar
  9. Jiang X, Huang PW, Zhong WM, Farkas T, Cubitt DW, Matson DO. Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR.J Virol Methods. 1999;83:14554. DOIPubMedGoogle Scholar
  10. Wang QH, Han MG, Cheetham S, Souza M, Funk JA, Saif LJ. Porcine noroviruses related to human noroviruses.Emerg Infect Dis. 2005;11:187481.PubMedGoogle Scholar
  11. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.J Virol. 1999;73:15260.PubMedGoogle Scholar
  12. Martella V, Campolo M, Lorusso E, Cavicchio P, Bellacicco AL, Decaro N, Norovirus in captive lion cub (Panthera leo).Emerg Infect Dis. 2007;13:10713.PubMedGoogle Scholar
  13. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature.Virology. 2006;346:31223. DOIPubMedGoogle Scholar
  14. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.Brief Bioinform. 2004;5:15063. DOIPubMedGoogle Scholar
  15. Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Taxonomy of the caliciviruses.J Infect Dis. 2000;181:S32230. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1408.080062

Table of Contents – Volume 14, Number 8—August 2008

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Vito Martella, Dipartimento di Sanità e Benessere Animale, Facoltà di Medicina Veterinaria di Bari, S.p. per Casamassima Km 3, 70010 Valenzano, Bari, Italy; .

Send To

10000 character(s) remaining.


Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.